Media for sperm capacitation and in-vitro fertilization (IVF) are supplemented by proteins (albumin, globulins) extracted from human or animal sera, which raises the problem of potential contamination by pathogens. The present study aimed to evaluate the efficiency of a proteinfree medium (SMART1 ® , Bio-Media, Boussens, France) and to compare it with a human serum albumin (HSA) containing medium (FertiCult ® , FertiPro NV, Aalter, Belgium). In the first part of the study, media were compared for their ability to support human sperm functions. Total motility, progressive motility and rapid motility were no different between media after a 30 min and a 4 h incubation, but were significantly reduced using SMART1 ® after a 24 h incubation. However, the kinematic parameters (straight line velocity, mean path velocity, curvilinear velocity and mean amplitude of lateral head displacement) were significantly lower using SMART1 ® , whatever the incubation time. The spontaneous acrosome reaction and the acrosome response to A23187 ionophore were similar in both media. In the second part of the study, media were compared in a randomized trial in 93 IVF attempts. No significant difference was found in the transfer per attempt rate (92 versus 87% respectively for SMART1 ® and FertiCult ® , NS) but the percentage of fertilized oocytes was significantly higher using SMART1 ® (65 versus 55% respectively for SMART1 ® and FertiCult ® , P Ͻ 0.01). The percentage of embryos with a fair morphology was identical in both media (30 versus 30% respectively for SMART1 ® and FertiCult ® , NS). In conclusion, despite a decrease in sperm kinematics, SMART1 ® medium allows an increase in fertilization rate and, since it is devoid of any human or animal compound, may be preferable for human use.
Introduction
Several protein sources have been used for the supplementation of media employed for in-vitro fertilization (IVF). In the early 1980s, most of the teams used patients' sera but it appeared that some sera were not able to support optimal embryo growth (Miller et al., 1995) , necessitating testing in a mouse embryo system prior to use (Tam et al., 1987) . To avoid these problems, bovine serum albumin (BSA) has been successfully used instead of patient or fetal cord serum (Ménézo et al., 1984; Parinaud et al., 1987) , but some allergic diseases, observed in IVF patients, have been related to the use of BSA (MoneretVautrin et al., 1991; Morales et al., 1994) and so human serum albumin (HSA) (Ashwood-Smith et al., 1989; Staessen et al., 1994) has replaced BSA in most media. More recently, good IVF results have been reported using serum substitutes such as synthetic serum substitute from Irvine Scientific (CA, USA) (Graham et al., 1995; Dugan et al., 1997) , which are, in fact, derived from pooled heat-inactivated sera (Parinaud, 1997) .
The use of proteins from human or animal sera raises two major questions: the variability in efficiency and the safety. Indeed, Dröge et al. (1982) have described wide variations in the fatty acid composition and in the isoionic pH among human serum albumin batches and the variability in albumin contents has been reported to influence the efficiency of culture media (Kane, 1983; Melsert et al., 1991) . Concerning safety, it has been shown that viruses, such as hepatitis B or HIV, could bind to albumin (Krone et al., 1990; Stefas et al., 1997) . Despite the effectiveness of the manufacturing processes of HSA in eradicating known viruses (Erstad, 1996) , it is quite impossible to eliminate hazards due to unknown pathogens (Truyen et al., 1995) .
These data have led us to develop a new culture medium devoid of any human or animal compound (SMART1 ® ; BioMedia, Boussens, France) and designed to support human in-vitro fertilization. Since sperm function and fertilization have different nutrient requirements than embryo growth (Sakkas et al., 1993) , this medium was specially composed for the first step of IVF, i.e. sperm capacitation and gamete interaction until zygote formation.
Materials and methods

Media
SMART1 ® , based on Earle's salts solution, contains glucose, amino acids, synthetic and plant molecules and is devoid of any human or animal compound. It is ready to use and does not require any supplementation.
FertiCult ® is based on Earle's balanced salts solution and contains 0.4% HSA.
BM1 ® (Ellios Bio-Media, Paris, France), is a complex medium, containing 1% HSA, high levels of glucose, low levels of pyruvate, non essential amino acids and vitamins.
Patients
For the study of sperm functions, 12 semen samples from 12 healthy volunteers were used. For technical reasons, the acrosome function could be assessed on only nine samples.
For the IVF study, 93 patients from 93 consecutive IVF attempts entered the study. The causes of infertility were as follows: tubal (52, 55%), endometriosis (7, 8%), ovarian dysfunction (3, 3%), male factor (17, 18%), and unexplained (14, 15%). Sperm were defined as normal or abnormal according to the WHO (1992) classification.
In-vitro fertilization procedures
Ovarian stimulation was performed using a combination of buserelin (Suprefact ® ; Hoechst, Puteaux, France) and recombinant FSH (Gonal-F 75 ® ; Serono, Paris, France) as previously described (Parinaud et al., 1993) . Two to 23 oocytes (mean: 9.1) were collected by ultrasonically guided puncture.
The oocytes were randomly placed, alternatively after recovery, in SMART1 ® medium or in FertiCult ® medium without any serum or substitute. They were inseminated with 50 000 spermatozoa in cases of normal sperm and with 200 000 spermatozoa in cases of abnormal sperm. After a 24 h incubation, the oocytes were observed for pronuclei assessment, and then transferred in BM1 ® medium. Since SMART1 ® is not designed to support embryo growth, we choose to incubate all zygotes in BM1 medium, to avoid any bias in the comparison of SMART1 ® and FertiCult ® media. Embryos were observed for quality scoring (Giorgetti et al., 1995) 48 h after follicular puncture (at the 2-cell or 4-cell stage); briefly, the score assigned one point for each of the following criteria: cleavage, absence of fragmentation, absence of irregularity and 4-cells. Two to four embryos (mean: 2.8) were transferred according to the patient's age.
The protocol was approved by the Comité Consultatif de Protection des Personnes dans la Recherche Biomédicale (Toulouse, France).
Sperm preparation
For all studies (sperm functions and IVF), after 30 min liquefaction at 37°C, motile spermatozoa were isolated using a discontinuous (60, 80, 90%) Percoll (Sigma Chemical Co., St Louis, MO, USA) gradient made with Tyrode's solution (GIBCO BRL, Cergy Pontoise, France). Following centrifugation for 30 min at 200 g, the 90% Percoll fraction was recovered and sperm cells were resuspended in 4 ml Tyrode's solution. This suspension was split into two equal parts and then centrifuged. One pellet was resuspended in SMART1 ® medium, the other in FertiCult ® medium. Of the 93 sperm samples, 70 (75%) were classified as normal and 23 (25%) as abnormal. Of the normal samples, 64 (91%) achieved fertilization in SMART1 ® and 61 (87%) in FertiCult ® . The corresponding values for the abnormal samples were 22 (96%) and 20 (87%) respectively.
Sperm kinematics
Motility parameters were assessed in 20 µl of semen for each sample in a 2-well microcell (BICEF, L'Aigle, France), after a 30 min, a 4 h and a 24 h incubation in either SMART1 ® or FertiCult ® , at 37°C using an Hamilton Thorn Motility Analyzer ® version 10.8 (Hamilton Thorn Research, Beverly, MA, USA). Machine parameters were frame rate of 25/s, minimum contrast 8, minimum size 6, low/high size gates 0.5/1.7, low/high intensity gates 0.4/1.7, non-motile head size 9, non-motile intensity 200 and a path velocity Ͼ5 µm/s to be counted as motile. The variables measured included the percentage motile, percentage progressive motility, straight line velocity (VSL), mean path velocity (VAP), curvilinear velocity (VCL), mean linearity, mean amplitude of lateral head displacement (ALH) and percentage of motile spermatozoa with a path velocity Ͼ 25 µm/s, defined as rapid motility. Hyperactivated motility was defined as follows: curvilinear velocity Ͼ100 µm/s, linearity Ͻ65% and amplitude of lateral head displacement Ͼ7.5 µm (Burkman, 1991) .
Spontaneous acrosome reaction
The spontaneous acrosome reaction (∆ 24 h) was determined as the difference between the percentages of reacted spermatozoa after a 1 h and a 24 h incubation at 37°C with 5% CO 2 .
Induction by calcium ionophore After a 6 h incubation at 37°C with 5% CO 2 in either SMART1 ® or FertiCult ® , spermatozoa were incubated 30 min in SMART1 ® or FertiCult ® media, containing 10 µmol/l calcium ionophore A 23187 (Sigma). Response (∆ A23187) was assessed by the difference between percentages of acrosome reacted spermatozoa before and after A23187 addition.
Assessment of acrosomal status
Acrosomal status and viability of spermatozoa were monitored as described by Mortimer et al. (1990) , combining the use of fluorescent peanut (Arachis hypogea) agglutinin lectin (Sigma) and Hoechst 33258 (Sigma). Spermatozoa were considered to be reacted when they were classified as equatorial segment or dark according to Mortimer et al. (1990) . In each sample, 200 spermatozoa were observed.
Statistical analysis
Data are means Ϯ SD. Statistical comparisons were performed using non-parametric Wilcoxon paired test, paired t-test or χ 2 test as appropriate.
Results
Comparison of the effects of SMART1 ® and FertiCult ® media on sperm functions As shown in Table I , the total motility, progressive motility and rapid motility were no different between media after a 30 min and a 4 h incubation, but were significantly reduced using SMART1 ® after a 24 h incubation. However, most of the kinematic parameters (straight line velocity, mean path velocity, curvilinear velocity, mean amplitude of lateral head displacement) were significantly lower using SMART1 ® , whatever the incubation time. By contrast, the acrosome function, assessed through the percentage of live acrosome-reacted spermatozoa, the spontaneous acrosome loss after a 24 hour incubation (∆ 24h) and the response to calcium ionophore (∆ A23187), did not exhibit any statistically significant difference between the two media (Table II) . Table III reports the results of 93 IVF attempts in which oocytes were randomly incubated in SMART1 ® or in FertiCult ® . There was no significant difference in the transfer per attempt rate but it must be noticed that in six cases fertilization was achieved only in SMART1 ® medium, while there was only one case where fertilization occurred only in FertiCult ® and not in SMART1 ® . The fertilization rate (embryos/inseminated oocytes) was significantly higher in SMART1 ® than in FertiCult ® despite no difference in the mean number of bound spermatozoa to the zona. No difference was found for the percentage of activated oocytes (0/420 versus 3/422 respectively for SMART1 ® and FertiCult ® , not significant) and of the 3 pronuclei zygotes (2/420 versus 1/422 respectively for Synthetic medium for fertilization SMART1 ® and FertiCult ® , not significant). The embryo quality, assessed through the score described by Giorgetti et al. (1995) , was identical in both media.
Results of IVF as a function of the medium used for fertilization
Discussion
The results of the present study show that the protein-free medium, SMART1 ® , is not only able to support in-vitro fertilization but also allows a higher percentage of fertilized oocytes than an HSA containing medium, FertiCult ® . Most of the kinematic parameters (VAP, VSL, VCL) at any incubation times, as well as the percentage of motile spermatozoa after a 24 h incubation, were significantly reduced using SMART1 ® rather than FertiCult ® . These data argue in favour of molecules, brought by albumin, able to increase sperm motility. It must be noticed that the difference in motility after a 24 h incubation is lower in the IVF study than in the sperm function one. This could be due to the presence of cumulus cells in the medium during IVF, which could release some compounds increasing motility. For instance, cumulus cells secrete progesterone which has been demonstrated to enhance cAMP in spermatozoa (Parinaud and Milhet, 1996) , which is necessary for motility. However, this decrease in motility did not affect the fertilization rate, which is even better with SMART1 ® . This is in agreement with previous work done in our laboratory, in which we have found that the motility parameters displaying the highest correlations with the fertilization rate were the progressive motility, the rapid motility and the linearity after a 30 min incubation (Parinaud et al., 1995a,b) ; all of these parameters were found to be identical in both media.
The percentage of live unreacted spermatozoa, which reflects the subpopulation able to fertilize, the spontaneous acrosome loss and the acrosome response to A23187, were identical in both media. This is an important finding since it has been previously reported that these parameters displayed statistically significant differences between IVF successes and failures, significant correlations with the fertilization rate and good predictive values for IVF results (Cummins et al., 1991; Fénichel et al., 1991) .
The fertilization rate was higher when IVF was performed in SMART1 ® than in FertiCult ® . This finding could reflect a higher capacitation stage of spermatozoa in SMART1 ® . Capacitation is associated with the expression of receptors on the sperm membrane such as α 5 and β 1 integrins (Fusi et al., 1996) or D-mannose receptors (Benoff et al., 1993) . Several molecules have been reported to enhance capacitation such as human endometrial sialic acid-binding protein (Banerjee and Chowdhury, 1997) , progesterone (Parinaud and Milhet, 1996; Revelli et al., 1998) or pGlu-Glu-Pro amide, a tripeptide called fertilization promoting peptide (Green et al., 1996) . It must be noticed that unlike FertiCult ® , SMART1 ® contains pGlu-Glu-Pro amide. Another explanation could be the presence of fatty acids, brought by albumin, in FertiCult ® . These fatty acids, which are absent in SMART1 ® , could be responsible for peroxidation of sperm membranes, which is known to impair sperm function (Aitken, 1995) . Despite the difference in the fertilization rates, the mean number of spermatozoa bound to the zona was identical in both media. However this count was done after mechanical removal of the cumulus cells and probably some of the spermatozoa were detached from the zona during this procedure; thus this count probably does not reflect the actual number of spermatozoa binding to the zona.
Since the randomization was done on an oocyte basis, it was not possible to evaluate the ability of the embryos obtained with SMART1 ® to further develop and implant. However, the embryo scores were identical and thus SMART1 ® allowed an increase in the number of available embryos with a good morphology (score 4 and 3) (80 versus 69 respectively for SMART1 ® and FertiCult ® ).
In conclusion, SMART1 ® appears to be more effective than FertiCult ® for sperm capacitation and fertilization and, since it is devoid of any human or animal compound, offers better security for patients.
